AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ALPHA GROWTH PLC

Interim / Quarterly Report Sep 17, 2024

4991_ir_2024-09-17_c489922b-2fec-43ef-a989-9cb72b1631f5.html

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3373E

Alpha Growth PLC

17 September 2024

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.  ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Alpha Growth plc

Unaudited interim report for six month period ended

30 June 2024

The Board of Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in life insurance-linked wealth and esoteric asset management, is pleased to announce its unaudited interim results for the six month period ended 30 June 2024.

Chairman's Statement

PERIOD ENDED 30 JUNE 2024

Key Highlights for the Period:

·      Revenue Growth: Achieved a 12% increase in revenues compared to the same period last year.

·      Significant move towards profitability: Reduced our loss before taxation to £0.14 million for the six months ended 30 June 2024, down from £0.42 million in the same period of 2023.

·      Progress in Integration: Integration projects are starting to yield positive results, bringing the Group closer to achieving operating breakeven.

·      Expansion and Innovation: Successfully enhanced assets within our insurance businesses and developed a new insurance product which is now ready for launch.

The Group is beginning to see the benefits of synergies across its diverse businesses and is excited to realize the full impact of our strategic initiatives as move forward. The Board is optimistic about achieving further substantial financial improvements and expects additional positive results from current projects, including the recent acquisition of Jeometri Insurance Managers (Guernsey) Limited, finalised in September 2024.

The Jeometri acquisition is expected to deliver significant opportunities for the Group, with the Jeometri team having already providing input in developing new products for Alpha International Life Assurance Company (Guernsey) Ltd ("AILAC"), which we anticipate will be highly attractive to the market.

We expect continued improvement in our cash flows and do not foresee the need for a share placement, unless it is for a strategic acquisition which will deliver material growth and which is significantly value and share price accretive.

Our buy-and-build strategy remains a priority and we are actively exploring additional acquisitions that complement and enhance our existing operations, and which will materially advance our plan to be managing over $2bn of AUM in 2025.

Whilst the Group has been advancing discussions with acquisition targets there can be no guarantee that these acquisitions will complete. The Directors however are confident that our existing strategy and value creation approach will ultimately be reflected in our share price.

I would like to express my gratitude to our shareholders for their continued support as we advance Alpha Growth into a leading organization in its sector.

Gobind Sahney

Chairman

17 September 2024

For more information, please visit www.algwplc.com or contact the following:

Alpha Growth plc +44 (0) 20 3959 8600
Gobind Sahney, Executive Chairman [email protected]
Allenby Capital Limited +44 (0) 20 3328 5656
Amrit Nahal (Sales and Corporate Broking)
Nick Athanas / Piers Shimwell (Corporate Finance)
UK Investor Relations - Mark Treharne [email protected]

RESULTS FOR THE PERIOD

INTERIM PERIOD ENDED 30 June 2024

The results of the Group have been addressed above in the Chairman's statement.

Responsibility Statement

We confirm that to the best of our knowledge:

(a)           the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting';

(b)           the interim management report includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year; and

(c)           the interim management report includes a fair review of the information required by DTR 4.2.8R (disclosure of related parties' transactions and changes therein).

CAUTIONARY STATEMENT

This Interim Management Report (IMR) has been prepared solely to provide additional information to shareholders to assess the Company's strategies and the potential for those strategies to succeed. The IMR should not be relied on by any other party or for any other purpose.

Going Concern

The Directors have a reasonable expectation that the Group has adequate resources to continue in operation or existence for the foreseeable future thus we continue to adopt the going concern basis in preparing these interim financial statements. As detailed in the Chairman's statement the on-going expected timing of transactions that the Company plans to be involved in and generate fees from, continue as planned and therefore should benefit the Group in the longer term.   

PRINCIPAL RISKS AND UNCERTAINTIES

The principal risks and uncertainties affecting the business activities of the Group are detailed on page 15 and 16 of the Annual Report and Financial Statements for the year ended 31 December 2023, a copy of which is available on the Company website at www.algwplc.com. The Board considers that these remain a current reflection of the risks and uncertainties facing the business for the remaining six months of the financial year.

Gobind Sahney

Director

17 September 2024

Alpha Growth plc

CONSOLIDATED Statement of comprehensive income

INTERIM period ENDED 30 june 2024

(Unaudited) (Unaudited) (Audited)
Six months Six months 12 months
Ended Ended Ended
30.6.2024 30.6.2023 31.12.2023
Notes £ £ £
Restated
Continuing operations
Revenue from Owned Insurance Companies 2,605,527 2,222,909 4,731,056
Revenue from Contracts with Clients 199,987 275,801 449,415
Other income 3,684 2,121 26,314
Total revenue 2,809,198 2,500,831 5,206,785
Amortisation of intangible assets (51,496) (29,620) (52,931)
Interest expense and investment costs (3,959) (15,095) (21,422)
Expenses in managing owned insurance companies (1,274,954) (1,240,409) (2,813,214)
Operating expenses (1,622,239) (1,637,643) (3,810,655)
(Loss) before taxation (143,450) (421,936) (1,491,437)
Taxation 27,523 31,156 135,182
Loss for the period (115,927) (390,780) (1,356,255)
Other comprehensive income
Items that may be reclassified subsequently to profit or loss:
Exchange differences on foreign operations 18,734 (76,650) 10,436
Total comprehensive income (97,193) (467,430) (1,345,819)
Attributable to:
Owners of the Company (97,193) (456,850) (1,335,239)
Non-controlling Interests - (10,580) (10,580)
(97,193) (467,430) (1,345,819)
Earnings / (loss) per share from continuing
operations attributable to the equity owners
Basic (loss)/earnings  per share (pence) 3 (0.02p) (0.1p) (0.2p)
Fully diluted (loss)/earnings per share (pence) 3 (0.02p) (0.1p) (0.2p)

Alpha Growth plc

CONSOLIDATED Statement of Financial Position

AS AT 30 june 2024

(Unaudited) (Unaudited) (Audited)
As at As at As at
30.6.2024 30.6.2023 31.12.2023
£ £ £
Restated
Assets
Cash and cash equivalents 4,537,657 5,050,071 7,420,418
Short term investments 363,819 337,913 360,430
Trade and other receivables 2,245,220 4,297,140 13,928,139
Loans to policyholders 10,571,396 6,653,367 10,178,506
Deferred tax asset 659,004 521,539 617,887
Right of use assets - - 143,422
Tangible fixed assets 39,545 -
Intangible assets 1,447,100 1,525,542 1,488,520
19,863,741 18,385,570 34,137,322
Assets backing unit-linked and contractual liabilities
Cash and cash equivalents - assets backing 2,328,343 8,460,707 10,950,357
Financial assets 450,034,659 417,550,206 423,770,659
452,363,002 426,010,913 434,721,016
Total assets 472,226,743 444,396,483 468,858,338
Liabilities
Trade and other payables 896,303 2,003,032 5,375,795
Income tax payable - 1,546 -
Policy claims payable 2,320,695 2,314,818 12,705,096
Short term loans 10,567,648 6,649,624 10,174,784
Lease liabilities 139,272 213,188 170,386
Provisions 325,753 431,808 -
14,249,671 11,614,016 28,426,061
Unit-linked and contractual liabilities
Unit-linked liabilities 445,259,848 418,919,671 427,809,449
Structured settlements 7,103,154 7,091,242 6,911,565
452,363,002 426,010,913 434,721,014
Total liabilities 466,612,673 437,624,929 463,147,075
Net Assets 5,614,070 6,771,554 5,711,263
Total Equity 5,614,070 6,771,554 5,711,263

Company number: 09734404

Alpha Growth plc

CONSOLIDATED Statement of Changes in Equity

INTERIM period ENDED 30 june 2024

Share Share Option Share-based Foreign Retained Total Non- Total
Capital Premium Reserve Payment Exchange Deficit Attributable to Controlling
Reserve Reserve Shareholders Interests
£ £ £ £ £ £ £ £ £
AS AT 31 DECEMBER 2022 as previously reported 431,887 5,388,152 815,474 113,390 182,748 (505,314) 6,426,337 282,098 6,708,435
Restatement to reflect elimination of insurance and reinsurance reserves - - - - - (85,420) (85,420) - (85,420)
AS AT 31 DECEMBER 2022 restated 431,887 5,388,152 815,474 113,390 182,748 (590,734) 6,340,917 282,098 6,623,015
Loss for the period (380,200) (380,200) (10,580) (390,780)
Foreign exchange gain on conversion of subsidiary - - - - (57,891) - (57,891) (18,759) (76,650)
Total comprehensive income for the period - - - - (57,891) (380,200) (438,091) (29,339) (467,430)
Shares issued 35,888 860,810 - - - - 896,698 - 896,698
Employee share options expired - - (145,526) - - 145,526 - - -
Exercise of warrrants - - - (113,390) - - (113,390) - (113,390)
Acquisition of non-controlling interests - - - - - - - (252,759) (252,759)
AS AT 30 JUNE 2023 467,775 6,248,962 669,948 - 124,857 (825,408) 6,686,134 - 6,686,134
Profit for the period - - - - - (965,475) (965,475) - (965,475)
Foreign exchange loss on conversion of subsidiary - - - - (9,396) - (9,396) 96,482 87,086
Total comprehensive income for the period - - - - (9,396) (965,475) (974,871) 96,482 (878,389)
Employee share options expired - - (8,035) - - 8,035 - - -
Acquisition of non-controlling interests - (96,482) (96,482)
AS AT 31 DECEMBER 2023 467,775 6,248,962 661,913 - 115,461 (1,782,848) 5,711,263 - 5,711,263
Loss for the period - - - - - (115,927) (115,927) - (115,927)
Foreign exchange gain on conversion of subsidiary - - - - 18,734 - 18,734 - 18,734
Total comprehensive income for the period - - - - 18,734 (115,927) (97,193) - (97,193)
AS AT 30 JUNE  2024 467,775 6,248,962 661,913 - 134,195 (1,898,775) 5,614,070 - 5,614,070

Alpha Growth plc

CONSOLIDATED Statement of Cash Flows

INTERIM PERIOD ENDED 30 june 2024

(Unaudited) (Unaudited) (Audited)
6 months 6 months 12 months
Ended Ended Ended
30.6.2024 30.6.2023 31.12.2023
£ £ £
Restated
OPERATING ACTIVITIES
Loss for the period before interest and taxation (143,175) (408,962) (1,496,329)
Adjusted for:
Services settled by way of payment in shares/options - 108,816 108,816
Amortisation of intangible assets and right of use assets 29,742 29,620 64,430
Gain on disposal of sublease - (45,156) (147,805)
Other non-cash movements 365,533 40,068 (451,301)
Operating cash outflows before movements in working capital: 252,100 (275,614) (1,922,189)
(Increase)/decrease in trade and other receivables 11,798,080 9,706,047 (121,410)
Increase/(decrease) in trade and other payables (4,493,086) (2,521,419) 910,701
Increase/(decrease) in short term loans (26) 7,924 179
Increase/(decrease) in policy claims (10,384,401) (9,945,182) 445,096
(Increase)/decrease in short term investments (3,389) 158 (14,594)
(Increase)/decrease in financial assets backing unit-linked liabilities (26,264,000) (3,503,242) (9,723,695)
Increase/(decrease) in unit linked liabilities and structured settlements 17,641,988 (5,494,242) 3,215,859
Net cash used in operating activities (11,452,734) (12,025,570) (7,210,053)
FINANCING ACTIVITIES
Repayment of leasing liabilities (39,495) (31,783) (68,097)
Sublease of premises including interest 26,055 32,370 171,439
Interest paid on leasing liabilities and loans - - (31,422)
Purchase of fixed assets (39,545) - -
Loan finance - (300,000) (350,000)
Other interest received 944 - 23,147
Net proceeds from issuance of shares net of issue costs - 344,390 344,390
Net cash (outflow)/inflow from financing activities (52,041) 44,977 89,457
Net (decrease)/increase in cash and cash equivalents (11,504,775) (11,980,593) (7,120,596)
Cash and cash equivalents at beginning of period 18,370,775 25,491,371 25,491,371
Cash and cash equivalents at end of period 6,866,000 13,510,778 18,370,775
Cash and cash equivalents at end of period consists of:
Cash and cash equivalents presented within assets 4,537,657 5,050,071 7,420,418
Cash and cash equivalents presented within assets backing unit-linked liabilities 2,328,343 8,460,707 10,950,357
Cash and cash equivalents at end of period 6,866,000 13,510,778 18,370,775

Alpha Growth plc

Notes to the Financial Statements

interim results to 30 june 2024

1.   Organisation and Trading Activities

The company is incorporated and domiciled in England and Wales as a public limited company and operates from its registered office 35 Berkeley Square, Mayfair London, United Kingdom W1J 5BF.

The principal activity of the Group is the provision of advice and consultancy services to institutional investors and existing and prospective holders of Senior Life Settlements through the management of its funds and the ownership of life insurance companies.

2.   Summary of Significant Accounting Policies

The principal accounting policies adopted and applied in the preparation of these interim Group Financial statements are set out below.

These have been consistently applied to all the periods presented unless otherwise stated:

Basis of accounting

These interim financial statements of Alpha Growth plc (the "Group") have been prepared in accordance with UK adopted international accounting standards ("UK-adopted IAS") applied in accordance with the provisions of the Companies Act 2006.

The interim financial statements have been prepared under the historical cost convention on the basis of the accounting policies as set out in the Group's audited annual financial statements and are presented in GBP £ the presentational and functional currency of the Group. The Group has applied IAS 34 in the preparation of these interim financial statements.

This announcement was approved and authorised by the Board of directors on 17 September 2024. Copies of this interim report will be made available on the Company's website at www.algwplc.com .

These condensed interim financial statements for the six months ended 30 June 2024 are unaudited and do not constitute fully prepared statutory accounts. The comparative figures for the 12 month period ended 31 December 2023 are extracted from the 2023 audited financial statements. The independent auditor's report on the 2023 financial statements contained disclaimer of opinion.

Going concern

Any consideration of the foreseeable future involves making a judgement, at a particular point in time, about future events which are inherently uncertain.

The Directors have a reasonable expectation that the Group has sufficient cash and liquid reserves in order to meet any future obligations and thus to continue operating for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the Financial Statements.

COMPARATIVE INFORMATION

The comparative information for the six month period to 30 June 2023 has been restated to make the information consistent with the audited financial statements for the year ended 31 December 2023. The restatement relates to the following areas:

·      Disaggregation of assets and liabilities in insurance businesses - the Directors' decided to present information relating to the life assurance subsidiaries on a disaggregated basis, rather than reporting two separate line items comprising total assets in insurance businesses and total liabilities in insurance businesses.

·      Restatement of sub-lease - the treatment of sub-lease has been amended to reflect the derecognition of the right of use asset and the recognition of an investment in sublease, in accordance with IFRS 16.

·      Treatment of lapsed share options - share options with passed vesting dates, previously reversed out in the Statement of comprehensive income, were restated to remain recognised in equity with a corresponding transfer within equity from share based payment reserve to retained earnings. This treatment results in a fairer presentation of the services received from the directors.

3.   EARNINGS / (LOSS) per Share

The basic earnings / (loss) per share is based on the loss for the period divided by the weighted average number of shares in issue during the year. The weighted average number of ordinary shares for the Company the period ended 30 June 2024 assumes that all shares have been included in the computation based on the weighted average number of days since issue. Since the Group has made a loss in the current and each of the prior periods, the warrants in issue are not dilutive. 

30.6.2024 30.6.2023 31.12.2023
£ £ £
Loss for the period from continuing operations: (115,927) (292,432) (1,356,255)
Weighted average number of ordinary shares in issue for basic earnings 467,775,068 447,084,823 458,046,069
Fully diluted average number of shares in issue 467,775,068 447,084,823 458,046,069
Basic earnings per share (0.02p) (0.1p) (0.2p)
Fully diluted earnings per share (0.02p) (0.1p) (0.2p)

4.   Share capital AND SHARE PREMIUM

Ordinary shares of £0.001 each Share capital Share premium
Number £ £
At 1 January 2023 431,887,388 431,887 5,388,152
Warrant exercise 18,750,000 18,750 469,640
Share issue as payment for services 17,137,680 17,138 421,780
Costs related to warrant exercise - - (30,610)
At 30 December 2023 467,775,068 467,775 6,248,962
At 30 June 2024 467,775,068 467,775 6,248,962

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IR QKABDCBKKOCD

Talk to a Data Expert

Have a question? We'll get back to you promptly.